Watchlist

Watchlist
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)
Daily Insider Ratings Round Up 5/17/18
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi…
FDA OKs first non-opioid treatment for opioid withdrawal
The FDA approves privately held US WorldMeds LLC's Lucemyra (lofexidine hydrochloride) for the management of opioid withdrawal symptoms in adults who abruptly discontinue opioids. More news on: Endo International plc, Allergan plc, Johnson & Johnson, Healthcare stocks news, Read …
Amphastar Pharmaceuticals' (AMPH) Q1 2018 Results - Earnings Call Transcript
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2018 Earnings Conference Call May 09, 2018 05:00 PM ET Executives Jason Shandell - President Bill Peters - CFO Analysts David Amsellem - Piper Jaffray David Maris - Wells Fargo Gary Nachman - BMO Capital Markets David Steinberg …
Amphastar misses by $0.13, misses on revenue
Amphastar (NASDAQ: AMPH ): Q1 EPS of -$0.05 misses by $0.13 . More news on: Amphastar, Earnings news and commentary, Healthcare stocks news, Read more …
Notable earnings after Wednesday's close
AG , ALB , AMPH , ANGI , ATUS , AYX , BLDR , BOLD , BREW , COLL , CPA , CTL , CVNA , DAR , DNB , EEP , ELF , ENV , ETE , ETP , EVH , FG , FGEN , FNGN , FNV , FOXA , FSM , FTI , FTK , GDOT , GKOS , HLI , IAC , ICUI , INFN , MBI , MELI , MRAM , MTRX , N…
Opioid prescriptions dropped 12% in 2017
Opioid prescriptions dropped 12% in 2017, according to a report from the IQVIA Institute for Human Data Science. More news on: Johnson & Johnson, Endo International plc, Teva Pharmaceutical Industries Limited, Healthcare stocks news, Read more …
U.S. opioid prescriptions down 12% last year, largest drop in 25 years
According to IQVIA ( IQV -0.8% ), U.S. opioid prescriptions declined 12% in 2017, the largest annual drop in 25 years as doctors respond to the opioid crisis. More news on: IQVIA Holdings, Inc., Insys Therapeutics, Inc., Johnson & Johnson, Healthcare stocks news, News on ETFs, …
DEA aiming to collar production of opioids
The U.S. Drug Enforcement Administration (DEA) has unveiled plans to restrict the amount of opioids made by drug firms if it believes the medications are being diverted for illicit use. The proposed new rules were announced today in a speech by Attorney General Jeff Sessions. More news o…
Sen. Sanders introduces bill to fine opioid makers for marketing practices
Reuters reports that U.S. Senator Bernie Sanders (I-VT) plans to introduce a bill today that would fine makers of opioid medications for deceptive marketing and implement harsh penalties for those found responsible for contributing to the drug epidemic. More news on: Insys Therapeutics, …
Will Opiant Pharma Solve The Biggest Crisis That The FDA Is Currently Facing?
In an interview with CNN on Thursday, Food and Drug Administration Commissioner Dr. Scott Gottlieb said that the opioid epidemic is still the biggest challenge that the FDA is currently facing. Last month, Trump administration announced a new plan to combat the epidemic by enactin…
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)